LARIX AS - Denmark 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2012 0 5.986.000 544.182 1
2010 0 5.887.150 543.958 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITY OF TROMSOE2
BIOTEST1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
DRK BLUTSPENDEDIENST BADEN WURTTEMBERG HESSEN GGMBH1
HOSPICES CIVILS DE LYON1
INSTYTUT POMNIK CENTRUM ZDROWIA DZIECKA1
KATHOLIEKE UNIVERSITEIT LEUVEN1
LUNDS UNIVERSITET1
OSLO UNIVERSITETSSYKEHUS HF1
PROPHYLIX PHARMA AS1
REGION HOVEDSTADEN1
REGION NORDJYLLAND1
SKANE LANS LANDSTING1
STOCKHOLMS LAENS LANDSTING1
TEKNOLOGISK INSTITUT1
THE UNIVERSITY OF MANCHESTER1
UNILABAS AS1
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ1
UNIVERSITETSSYKEHUSET NORDNORGE HF1
ZYMENEX AS1

Constancy:

Total number of partners: 21
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 21
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2012-08-01Development of a prophylactic treatment for the prevention of fetal/neonatal alloimmune thrombocytopenia (FNAIT) PROFNAITparticipant5.986.00011
2010-10-01Clinical development of Enzyme Replacement Therapy in alpha-Mannosidosis patients using recombinant human enzyme ALPHA-MANparticipant5.887.15012